From: Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome
Total N (%)
240 (100)
Age at diagnosis
71.6
Gender
Female
101 (42.8)
Male
139 (57.9)
Sub-location tumor
Proximal
109 (45.4)
Distal
87 (36.6)
Rectosigmoid
44 (18.3)